| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/03/2004 | CA2505169A1 Collagen-based materials and methods for treating synovial joints |
| 06/03/2004 | CA2505167A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | CA2504930A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 06/03/2004 | CA2504267A1 Interferon-alpha polypeptides and conjugates |
| 06/03/2004 | CA2502700A1 Diagnostic method for celiac sprue |
| 06/02/2004 | EP1424557A1 Use of g protein-coupled receptor protein |
| 06/02/2004 | EP1424394A2 TAT transdominant variants from HIV virus |
| 06/02/2004 | EP1424393A2 Mammalian cytokine-like polypeptide-10 |
| 06/02/2004 | EP1424392A1 Novel secretory proteins and dna thereof |
| 06/02/2004 | EP1424344A1 Modified cDNA factor VIII and its derivates |
| 06/02/2004 | EP1424342A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide |
| 06/02/2004 | EP1424080A1 Gnrh agonist combination drugs |
| 06/02/2004 | EP1424078A1 Remedies for respiratory diseases comprising sphingosine-1-phosphate receptor controller |
| 06/02/2004 | EP1424077A1 Isulin-containing oral spray and the preparation method thereof |
| 06/02/2004 | EP1424074A1 Nutritional compositions for controlling blood glucose level |
| 06/02/2004 | EP1424066A1 Dry compositions comprising hydrophobic stabilisers |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423693A1 Erythropoietin and anti-tumor necrosis factor alpha combination therapy |
| 06/02/2004 | EP1423519A2 G-protein coupled receptor and dna sequences thereof |
| 06/02/2004 | EP1423515A1 Anti-aging and wound healing compounds |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423510A2 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 06/02/2004 | EP1423509A2 Differentiation of neural stem cells and therapeutic use thereof |
| 06/02/2004 | EP1423428A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 06/02/2004 | EP1423425A2 Receptor, the use thereof, and mouse antibodies |
| 06/02/2004 | EP1423424A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 06/02/2004 | EP1423423A2 Methods for construction and screening of libraries of chemokine variants |
| 06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
| 06/02/2004 | EP1423415A2 Intracellular signaling molecules |
| 06/02/2004 | EP1423414A1 Novel depsipeptides and process for preparing same |
| 06/02/2004 | EP1423413A1 Peptidic compounds selectively binding to p-selectin |
| 06/02/2004 | EP1423412A2 Homing peptides |
| 06/02/2004 | EP1423411A2 Prodrugs of excitatory amino acids |
| 06/02/2004 | EP1423410A2 Peptides having a c-terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i |
| 06/02/2004 | EP1423409A2 Gastrokines and derived peptides including inhibitors |
| 06/02/2004 | EP1423406A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 06/02/2004 | EP1423404A2 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/02/2004 | EP1423402A2 Novel polypeptide analogs and fusions and their methods of use |
| 06/02/2004 | EP1423373A2 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 06/02/2004 | EP1423169A2 Potentiator composition comprising a terpene for enhancing the therapeutical effect of antitumoral agents in the treatment of cancer |
| 06/02/2004 | EP1423154A2 Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments |
| 06/02/2004 | EP1423150A2 Sustained release of microcrystalline peptide suspensions |
| 06/02/2004 | EP1423144A2 Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease |
| 06/02/2004 | EP1423143A2 Crystal forms and mutants of rank ligand |
| 06/02/2004 | EP1423140A2 Compositions and methods for modulation of immune responses |
| 06/02/2004 | EP1423139A2 New use of artemin, a member of the gdnf ligand family |
| 06/02/2004 | EP1423138A2 Use of il-18 inhibitors in hypersensitivity disorders |
| 06/02/2004 | EP1423137A2 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates |
| 06/02/2004 | EP1423136A1 Polypeptide conjugates with extended circulating half-lives |
| 06/02/2004 | EP1423135A2 Methods for inhibiting angiogenesis |
| 06/02/2004 | EP1423134A2 Human secreted proteins |
| 06/02/2004 | EP1423133A2 Treatment of muscular dystrophies and related disorders |
| 06/02/2004 | EP1423110A2 Cbi analogues of cc-1065 and the duocarmycins |
| 06/02/2004 | EP1423095A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/02/2004 | EP1423012A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 06/02/2004 | EP1423002A1 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent |
| 06/02/2004 | EP1242109A4 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
| 06/02/2004 | EP1227824B1 Transplant/implant device and method for its production |
| 06/02/2004 | EP1098635B1 Enteric coated pharmaceutical tablet containing didanosine |
| 06/02/2004 | EP0981541B1 Psca: prostate stem cell antigen |
| 06/02/2004 | EP0959874B1 High dose liposomal aerosol formulations |
| 06/02/2004 | EP0948344A4 Synthetic antibiotics |
| 06/02/2004 | EP0941334B1 Protease-activatable pseudomonas exotoxin a-like proproteins |
| 06/02/2004 | EP0941105A4 Pretraumatic use of hemoglobin |
| 06/02/2004 | EP0891376B1 Antifungal peptides from scleroderma texense |
| 06/02/2004 | EP0813598B1 Thrombin preparation |
| 06/02/2004 | EP0807178B1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 06/02/2004 | EP0792279B1 Antibiotic cryptdin peptides and methods of their use |
| 06/02/2004 | EP0724638B1 Avian interferon genes and novel recombinant dna |
| 06/02/2004 | CN1501976A Crf2 ligands in combination therapy |
| 06/02/2004 | CN1501942A Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 06/02/2004 | CN1501940A Composition and method for inhibiting platelet aggregation |
| 06/02/2004 | CN1501826A Device for percutaneous transdermal delivery having coated micro-protrusions |
| 06/02/2004 | CN1501815A New interferon beta-like molecules |
| 06/02/2004 | CN1501812A Antithrombotic agents |
| 06/02/2004 | CN1501811A Compositions for stimulating cytokine secretion and inducing an immune response |
| 06/02/2004 | CN1501810A Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis |
| 06/02/2004 | CN1501809A Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 06/02/2004 | CN1501808A The use of the protein uk114 for the treatment and the prevention of chronic active hepatitis |
| 06/02/2004 | CN1501807A Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock |
| 06/02/2004 | CN1501804A Acrochordon alleviation |
| 06/02/2004 | CN1500876A Full length polynucleotide order of coding fowl ó� type collagen and uses thereof |
| 06/02/2004 | CN1500873A Nereides protease, separating and purifying method and application thereof |
| 06/02/2004 | CN1500820A Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 06/02/2004 | CN1500810A Fibroblast growth factor-2 analogue, producing process and application thereof |
| 06/02/2004 | CN1500809A Fibroblast growth factor-2 analogue, producing process and application thereof |
| 06/02/2004 | CN1500808A Recombination of human soluble TRAIL protein, the preparing method and the application in preparing antineoplastic medicine |
| 06/02/2004 | CN1500807A Method for diagnosing and curing alopecia utilizing the Rhor gene of human and rat and the encoding products |
| 06/02/2004 | CN1500781A Inhibitors of interleukin-1 beta converting enzyme |
| 06/02/2004 | CN1500523A Protein preparation for enhancing sclerotin and its preparation method |
| 06/02/2004 | CN1500475A Diffusional implantable delivery system |
| 06/02/2004 | CN1152137C Method for preparing human interleukin 4 using gene engineering and its expression vector and engineering bacterium |
| 06/02/2004 | CN1152134C Process for preparing recombinant deoxyribonuclease I |
| 06/02/2004 | CN1152051C Trichosanthin mutant and preparing method thereof |
| 06/02/2004 | CN1152049C Treatment of insulin resistance with growth hormone secretagogues |
| 06/02/2004 | CN1152048C Perfluoroalkyl ketone inhibitors of elastase and preparing method thereof |
| 06/02/2004 | CN1152039C Benzo (b) thiepine-1, 1-dioxide derivatives, producing method thereof, combination containing the same and uses thereof |
| 06/02/2004 | CN1151843C Novel anti-tumor medicine and its screening method and use |
| 06/02/2004 | CN1151842C Stable isotonic lyophilized protein formulation |
| 06/02/2004 | CN1151841C Application of interferons(IFN) in preparation of pharmaceutics for stimulation of defence mechanism or immune reaction |